Immunic to Participate in Investor and Scientific Conferences in February
Press Releases
Immunic, Inc.  
February 4, 2025

Immunic to Participate in Investor and Scientific Conferences in February

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases,

logo salamanca press

Salamanca Press

Local & Social